Amedisys, Inc. (AMED)

$96.79

-3.66 (-3.64%)
Rating:
Recommendation:
Strong Buy
Symbol AMED
Price $96.79
Beta 0.943
Volume Avg. 0.36M
Market Cap 3.140B
Shares () -
52 Week Range 96.45-188.88
1y Target Est -
DCF Unlevered AMED DCF ->
DCF Levered AMED LDCF ->
ROE 14.81% Buy
ROA 7.01% Neutral
Operating Margin -
Debt / Equity 97.60% Buy
P/E 23.49 Strong Buy
P/B 3.19 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest AMED news


Mr. Paul Kusserow
Healthcare
Medical Care Facilities
NASDAQ Global Select

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.